Skip to content

To study the outcome related to early (within 2-3 weeks of illness) versus delayed (in 4th week of illness) drainage of infected pancreatic fluid collections in patients with acute pancreatitis

Early versus Delayed Percutaneous Drainage for Infected Acute Fluid Collections in Acute Pancreatitis : A Randomised Controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/11/010476
Enrollment
100
Registered
2017-11-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K80-K87- Disorders of gallbladder, biliary tract and pancreas Health Condition 2: null- Patient with Acute pancreatitis having acute fluid collection presenting in less than 14 days of onset of pancreatitis

Interventions

Intervention1: Group 1- Early drainage: In this group, patients will undergo percutaneous pigtail drainage within 2-3 days of suspected infected acute fluid collection during the second or third wee

Sponsors

No sponsor
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (i) Patients with acute pancreatitis diagnosed as per revised Atlanta classification (ii) Hospitalisation within 14 days of onset of pancreatitis (iii) Patient suspected to have infected acute fluid collection (iv) Providing consent for study

Exclusion criteria

Exclusion criteria: (i) Age 75 years (ii) Patients with systemic organ dysfunction in the form of altered sensorium and/or hypotension requiring inotropic support and/or respiratory failure requiring mechanical ventilation and/or acute kidney injury requiring hemodialysis at the time of enrolment in the study. (iii) Other major co-morbid conditions e.g. Acute myocardial infarction, major gastrointestinal bleeding, chronic kidney disease, cirrhosis of the liver, human immunodeficiency virus (HIV) infection.

Design outcomes

Primary

MeasureTime frame
Composite Primary Outcome: (i) New organ failure or deterioration in existing organ failure (ii) Need for necrosectomy due to failure to control sepsis (iii) Mortality Timepoint: 3 to 12 weeks

Secondary

MeasureTime frame
(i) Hospital stay (ii) Resistant organism, fungal infection Timepoint: 3 months

Countries

India

Contacts

Public ContactDr Swatantra Gupta

All India Institute of Medical Sciences, New Delhi

pgarg10@gmail.com09868397205

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026